價(jià)格 | ¥7890 | ¥497 | ¥869 |
包裝 | 100mg | 2mg | 5mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-12-12 |
中文名稱(chēng):化合物 Naquotinib mesylate | 英文名稱(chēng):Naquotinib mesylate |
CAS:1448237-05-5 | 品牌: TargetMol |
產(chǎn)地: 美國(guó) | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
產(chǎn)品類(lèi)別: 抑制劑 | |
貨號(hào): T12175 |
Name | Naquotinib mesylate |
Description | Naquotinib mesylate (ASP8273 (mesylate)) is an orally available, mutant-selective and irreversible inhibitor of EGFR(iC50s of 8-33 nM and 230 nM for toward EGFR mutants and EGFR). |
In vitro | In NCI-H1650 (del ex19), Naquotinib inhibits cell growth with an IC50 value of 70nM while other EGFR-TKIs are only partially effective.Naquotinib selectively inhibits phosphorylation of EGFR and its down-stream signal pathway, ERK and Akt from 10nM in HCC827 and NCI-H1975 while inhibitory effects are only detected at 1000nM in A431[2]. |
In vivo | In an NCI-H1975 xenograft model, complete regression of tumor is achieved after 14-days of Naquotinib treatment.?Complete regression is maintained in 50% of mice more than 85 days after cessation of Naquotinib treatment[2]. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO : 12.5 mg/mL (18.97 mM), Sonication and heating are recommended. |
Keywords | EGFR | ErbB-1 | Inhibitor | ASP8273 | Naquotinib mesylate | ASP 8273 | HER1 | Epidermal growth factor receptor | inhibit | Naquotinib Mesylate | ASP-8273 | Naquotinib |
Inhibitors Related | Lapatinib | Neratinib | Chalcone | Gefitinib | Erlotinib | Osimertinib | Erlotinib hydrochloride | Afatinib Dimaleate | Lidocaine Hydrochloride hydrate | Genistein | Khellin | Osimertinib mesylate |
成立日期 | 2013-04-18 (12年) | 注冊(cè)資本 | 566.265100萬(wàn)人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營(yíng)行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營(yíng)模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱(chēng) | 價(jià)格 | 公司名稱(chēng) | 報(bào)價(jià)日期 | |
---|---|---|---|---|
詢(xún)價(jià) |
VIP5年
|
南昌探真生物技術(shù)有限公司
|
2024-12-26 | |
詢(xún)價(jià) |
VIP4年
|
陜西締都醫(yī)藥化工有限公司
|
2025-01-13 | |
詢(xún)價(jià) |
VIP3年
|
陜西締都醫(yī)藥化工有限公司
|
2025-01-03 | |
詢(xún)價(jià) |
VIP6年
|
上海澤葉生物科技有限公司
|
2025-01-20 |